| Cotargeting BCL-2 and PI3K induces BAX-dependent mitochondrial apoptosis in AML cells M Rahmani, J Nkwocha, E Hawkins, X Pei, RE Parker, M Kmieciak, ... Cancer research 78 (11), 3075-3086, 2018 | 106 | 2018 |
| MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity AB Lee-Sherick, KM Jacobsen, CJ Henry, MG Huey, RE Parker, LS Page, ... JCI insight 3 (21), 2018 | 50 | 2018 |
| MERTK mediates intrinsic and adaptive resistance to AXL-targeting agents NK McDaniel, CT Cummings, M Iida, J Hülse, HE Pearson, E Vasileiadi, ... Molecular cancer therapeutics 17 (11), 2297-2308, 2018 | 39 | 2018 |
| Co-administration of the mTORC1/TORC2 inhibitor INK128 and the Bcl-2/Bcl-xL antagonist ABT-737 kills human myeloid leukemia cells through Mcl-1 down-regulation and AKT inactivation M Rahmani, MM Aust, E Hawkins, RE Parker, M Ross, M Kmieciak, ... Haematologica 100 (12), 1553, 2015 | 37 | 2015 |
| MERTK Promotes Resistance to Irreversible EGFR Tyrosine Kinase Inhibitors in Non–small Cell Lung Cancers Expressing Wild-type EGFR Family Members D Yan, RE Parker, X Wang, SV Frye, HS Earp III, D DeRyckere, ... Clinical Cancer Research 24 (24), 6523-6535, 2018 | 27 | 2018 |
| Highly selective MERTK inhibitors achieved by a single methyl group J Zhao, D Zhang, W Zhang, MA Stashko, D DeRyckere, E Vasileiadi, ... Journal of Medicinal Chemistry 61 (22), 10242-10254, 2018 | 21 | 2018 |
| Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms T Nguyen, R Parker, E Hawkins, B Holkova, V Yazbeck, A Kolluri, ... Oncotarget 8 (19), 31478, 2017 | 19 | 2017 |
| Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms T Nguyen, R Parker, Y Zhang, E Hawkins, M Kmieciak, W Craun, S Grant BMC cancer 18, 1-11, 2018 | 18 | 2018 |
| Data-driven construction of antitumor agents with controlled polypharmacology C Da, D Zhang, M Stashko, E Vasileiadi, RE Parker, KA Minson, MG Huey, ... Journal of the American Chemical Society 141 (39), 15700-15709, 2019 | 13 | 2019 |
| IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB–and caspase-8–dependent mechanisms L Zhou, Y Zhang, MB Meads, Y Dai, Y Ning, X Hu, L Li, K Sharma, ... Blood Advances 5 (19), 3776-3788, 2021 | 10 | 2021 |
| The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivo B Rackley, CS Seong, E Kiely, RE Parker, M Rupji, B Dwivedi, ... Communications Biology 4 (1), 142, 2021 | 5 | 2021 |
| MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity. JCI Insight AB Lee-Sherick, KM Jacobsen, CJ Henry, MG Huey, RE Parker, LS Page, ... | 5 | 2018 |
| MERTK is a potential therapeutic target in osimertinib-resistant non-small cell lung cancer D Yan, J Huelse, R Parker, X Wang, SV Frye, HS Earp, D DeRyckere, ... Cancer Research 79 (13_Supplement), 4765-4765, 2019 | 2 | 2019 |
| Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancer J Koo, CS Seong, RE Parker, B Dwivedi, RA Arthur, AR Dinasarapu, ... bioRxiv, 2023 | 1 | 2023 |
| MERTK drives residual tumor growth in EGFR-mutated non-small cell lung cancer cells treated with osimertinib D Yan, J Huelse, R Parker, Z Tan, X Wang, SV Frye, HS Earp, ... Cancer Research 80 (16_Supplement), 1882-1882, 2020 | 1 | 2020 |
| Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms T Nguyen, R Parker, E Hawkins, B Holkova, V Yazbeck, A Kolluri, ... Oncotarget 10 (51), 5383, 2019 | 1 | 2019 |
| Mertk Inhibition Promotes Anti-Leukemia Immunity By Reversing T Cell Suppression Via the PD-1 Axis A Lee-Sherick, K Jacobsen, CJ Henry, R Parker, X Wang, SV Frye, ... Blood 132, 4019, 2018 | 1 | 2018 |
| Results from Five Years of the University of Arkansas System Division of Agriculture Corn Irrigation Yield Contest CG Henry, T Clark, R Parker, JP Pimentel Arkansas, 44, 2023 | | 2023 |
| Results from Five Years of the University of Arkansas System Division of Agriculture Rice Irrigation Yield Contest CG Henry, T Clark, R Parker, JP Pimentel Arkansas Rice Research Studies2022, 223, 2023 | | 2023 |
| An isogenic H/N/KRAS-less mouse embryonic fibroblast cell line panel derived from a size sorted diploid clonal parent RE Parker, J Koo, B Dwivedi, AI Marcus, M Gilbert-Ross MOLECULAR CANCER RESEARCH 21 (5), 2023 | | 2023 |
